脂质代谢异常与抑郁症发展的关联及机制研究进展

doi:10.12114/j.issn.1007-9572.2024.0233

中国全科医学 ›› 2025, Vol. 28 ›› Issue (20): 2562-2569.DOI: 10.12114/j.issn.1007-9572.2024.0233

所属专题：心理健康最新文章合辑

脂质代谢异常与抑郁症发展的关联及机制研究进展

李欣悦¹, 吴民民¹, 朱路文²^,³^,^*()

1．150040　黑龙江省哈尔滨市，黑龙江中医药大学
2．150001　黑龙江省哈尔滨市，黑龙江中医药大学附属第二医院康复中心
3．150000　黑龙江省哈尔滨市，黑龙江省脑功能与神经康复重点实验室

收稿日期:2024-05-16 修回日期:2024-07-18 出版日期:2025-07-15 发布日期:2025-05-28
通讯作者: 朱路文
作者贡献：
李欣悦负责文章的构思与设计、论文撰写；吴民民负责论文修订、文章的质量控制；朱路文负责资金支持、项目管理、监督管理。
基金资助:
国家自然科学基金资助项目(82174477); 黑龙江省重点研发项目(2022ZX06C24)

Exploration of the Association and Mechanism between Abnormal Lipid Metabolism and Depressive Development

LI Xinyue¹, WU Minmin¹, ZHU Luwen²^,³^,^*()

1. Heilongjiang University of Chinese Medicine, Harbin 150040, China
2. Rehabilitation Center, the Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150001, China
3. Heilongjiang Provincial Key Laboratory of Brain Function and Neurorehabilitation, Harbin 150000, China

Received:2024-05-16 Revised:2024-07-18 Published:2025-07-15 Online:2025-05-28
Contact: ZHU Luwen

分享到

摘要/Abstract

摘要： 脂质代谢是人体关键的生理过程，其紊乱与抑郁症的发生和发展密切联系。尽管如此，目前对这些联系的系统性整理尚不充分。本文综合探讨了抑郁症患者的脂质代谢变化，并详细阐述了脂质代谢紊乱与抑郁症共病关系的疾病，如超重、肥胖以及代谢综合征。另外，本文总结了5个脂质代谢异常与抑郁症发展相关的内在机制：α-突触核蛋白基因（SNCA基因）的过表达和α-突触核蛋白（α-Syn）的异常积聚、铁死亡、肠道菌群失调、线粒体质量控制系统障碍以及慢性应激。最后，本文提出了未来研究方向，为抑郁症的早期诊断与治疗提供了新的视角和研究基础。

关键词: 抑郁症, 脂类代谢, 机制, α-突触核蛋白, 多不饱和脂肪酸

Abstract:

Lipid metabolism is a key physiological process in the human body, and its disruption is closely omected with the onset and development of depression. Nevertheless, a systematic collation of these associations is currently inadequate. This article comprehensively explored the changes in lipid metabolism in patients with depression and elaborates on disorders in which disorders of lipid metabolism were co-morbidly associated with depression, such as overweight, obesity and metabolic syndrome. In addition, the article summarised five intrinsic mechanisms by which abnormalities in lipid metabolism were associated with the development of depression: overexpression of SNCA genes and abnormal accumulation of α-Syn, iron death, dysbiosis of gut microbiota, impairment of mitochondrial quality control systems, and chronic stress. Finally, this article suggested future research directions aimed at providing a new perspective and research basis for the early diagnosis and treatment of depression.

Key words: Depression, Lipid metabolism, Mechanism, Alpha-synuclein, Polyunsaturated fatty acids

中图分类号:

R 749.41 R 349.11

李欣悦,吴民民,朱路文. 脂质代谢异常与抑郁症发展的关联及机制研究进展[J]. 中国全科医学, 2025, 28(20): 2562-2569. DOI: 10.12114/j.issn.1007-9572.2024.0233.
LI Xinyue,WU Minmin,ZHU Luwen. Exploration of the Association and Mechanism between Abnormal Lipid Metabolism and Depressive Development[J]. Chinese General Practice, 2025, 28(20): 2562-2569. DOI: 10.12114/j.issn.1007-9572.2024.0233.

参考文献 60

[1]	世界卫生组织. "抑郁障碍（抑郁症）" [EB/OL].（2023-03-31）[2024-07-31].
[2]	ESTRELA M，HERDEIRO M T，FERREIRA P L，et al. The use of antidepressants，anxiolytics，sedatives and hypnotics in Europe：focusing on mental health care in Portugal and prescribing in older patients[J]. Int J Environ Res Public Health，2020，17（22）：8612. DOI：10.3390/ijerph17228612.
[3]	DU T F，LI G X，LUO H Y，et al. Hippocampal alpha-synuclein mediates depressive-like behaviors[J]. Brain Behav Immun，2021，95：226-237. DOI：10.1016/j.bbi.2021.03.020.
[4]	ZHANG G H，LV S M，ZHONG X，et al. Ferroptosis：a new antidepressant pharmacological mechanism[J]. Front Pharmacol，2023，14：1339057. DOI：10.3389/fphar.2023.1339057.
[5]	LIU L X，WANG H Y，CHEN X Y，et al. Gut microbiota and its metabolites in depression：from pathogenesis to treatment[J]. EBioMedicine，2023，90：104527. DOI：10.1016/j.ebiom.2023.104527.
[6]	JIANG M R，WANG L Y，SHENG H. Mitochondria in depression：the dysfunction of mitochondrial energy metabolism and quality control systems[J]. CNS Neurosci Ther，2024，30（2）：e14576. DOI：10.1111/cns.14576.
[7]	FULTON S，DÉCARIE-SPAIN L，FIORAMONTI X，et al. The menace of obesity to depression and anxiety prevalence[J]. Trends Endocrinol Metab，2022，33（1）：18-35. DOI：10.1016/j.tem.2021.10.005.
[8]	YOON J H，SEO Y，JO Y S，et al. Brain lipidomics：from functional landscape to clinical significance[J]. Sci Adv，2022，8（37）：eadc9317. DOI：10.1126/sciadv.adc9317.
[9]	TREVIÑO-ALVAREZ A M，SÁNCHEZ-RUIZ J A，BARRERA F J，et al. Weight changes in adults with major depressive disorder：a systematic review and meta-analysis of prospective studies[J]. J Affect Disord，2023，332：1-8. DOI：10.1016/j.jad.2023.03.050.
[10]	GAFOOR R，BOOTH H P，GULLIFORD M C. Antidepressant utilisation and incidence of weight gain during 10 years' follow-up：population based cohort study[J]. BMJ，2018，361：k1951. DOI：10.1136/bmj.k1951.
[11]	KIM E Y，LEE Y B，LEE G N，et al. Associations between body weight change and incidence of major depressive disorder in patients with type 2 diabetes mellitus：a nationwide longitudinal follow-up cohort study of 1.1 million[J]. Psychol Med，2024：1-9. DOI：10.1017/S0033291724000515.
[12]	LING J J，KEILP J G，GALFALVY H C，et al. Plasma phospholipid polyunsaturated fatty acid associations with neurocognition[J]. Nutrients，2023，15（21）：4542. DOI：10.3390/nu15214542.
[13]	BHARTI V，BHARDWAJ A，HOOD K，et al. A systematic review and meta-analysis of lipid metabolomic signatures of Major Depressive Disorder[J]. J Psychiatr Res，2021，139：197-205. DOI：10.1016/j.jpsychires.2021.05.036.
[14]	HUMMEL J，WESTPHAL S，WEBER-HAMANN B，et al. Serum lipoproteins improve after successful pharmacologic antidepressant treatment：a randomized open-label prospective trial[J]. J Clin Psychiatry，2011，72（7）：885-891. DOI：10.4088/JCP.09m05853blu.
[15]	ZORKINA Y，USHAKOVA V，OCHNEVA A，et al. Lipids in psychiatric disorders：functional and potential diagnostic role as blood biomarkers[J]. Metabolites，2024，14（2）：80. DOI：10.3390/metabo14020080.
[16]	VAN DER HEIJDEN A R，HOUBEN T. Lipids in major depressive disorder：new kids on the block or old friends revisited？[J]. Front Psychiatry，2023，14：1213011. DOI：10.3389/fpsyt.2023.1213011.
[17]	CUSSOTTO S，DELGADO I，ORIOLO G，et al. Low omega-3 polyunsaturated fatty acids predict reduced response to standard antidepressants in patients with major depressive disorder[J]. Depress Anxiety，2022，39（5）：407-418. DOI：10.1002/da.23257.
[18]	AYYASH A，HOLLOWAY A C. Fluoxetine-induced hepatic lipid accumulation is mediated by prostaglandin endoperoxide synthase 1 and is linked to elevated 15-deoxy-Δ12，14 PGJ2[J]. J Appl Toxicol，2022，42（6）：1004-1015. DOI：10.1002/jat.4272.
[19]	PINTO B，CONDE T，DOMINGUES I，et al. Adaptation of lipid profiling in depression disease and treatment：a critical review[J]. Int J Mol Sci，2022，23（4）：2032. DOI：10.3390/ijms23042032.
[20]	DREGAN A，RAYNER L，DAVIS K A S，et al. Associations between depression，arterial stiffness，and metabolic syndrome among adults in the UK biobank population study：a mediation analysis[J]. JAMA Psychiatry，2020，77（6）：598-606. DOI：10.1001/jamapsychiatry.2019.4712.
[21]	CHAN K L，POLLER W C，SWIRSKI F K，et al. Central regulation of stress-evoked peripheral immune responses[J]. Nat Rev Neurosci，2023，24（10）：591-604. DOI：10.1038/s41583-023-00729-2.
[22]	BREMNER J D，MOAZZAMI K，WITTBRODT M T，et al. Diet，stress and mental health[J]. Nutrients，2020，12（8）：2428. DOI：10.3390/nu12082428.
[23]	CLARK T D，CREAN A J，SENIOR A M. Obesogenic diets induce anxiety in rodents：a systematic review and meta-analysis[J]. Obes Rev，2022，23（3）：e13399. DOI：10.1111/obr.13399.
[24]	FARLEY G，RIGGS D W，BHATNAGAR A，et al. Omega-3 polyunsaturated fatty acids modify the inverse association between systemic inflammation and cardiovascular fitness[J]. Clin Nutr，2021，40（6）：4097-4105. DOI：10.1016/j.clnu.2021.02.006.
[25]	PAN A，KEUM N，OKEREKE O I，et al. Bidirectional association between depression and metabolic syndrome：a systematic review and meta-analysis of epidemiological studies[J]. Diabetes Care，2012，35（5）：1171-1180. DOI：10.2337/dc11-2055.
[26]	ZHANG M，CHEN J，YIN Z Q，et al. The association between depression and metabolic syndrome and its components：a bidirectional two-sample Mendelian randomization study[J]. Transl Psychiatry，2021，11（1）：633. DOI：10.1038/s41398-021-01759-z.
[27]	CHAN K L，POLLER W C，SWIRSKI F K，et al. Central regulation of stress-evoked peripheral immune responses[J]. Nat Rev Neurosci，2023，24（10）：591-604. DOI：10.1038/s41583-023-00729-2.
[28]	SVANBERGSSON A，EK F，MARTINSSON I，et al. FRET-based screening identifies p38 MAPK and PKC inhibition as targets for prevention of seeded α-synuclein aggregation[J]. Neurotherapeutics，2021，18（3）：1692-1709. DOI：10.1007/s13311-021-01070-1.
[29]	SARCHIONE A，MARCHAND A，TAYMANS J M，et al. Alpha-synuclein and lipids：the elephant in the room?[J]. Cells，2021，10（9）：2452. DOI：10.3390/cells10092452.
[30]	BATTIS K，XIANG W，WINKLER J. The bidirectional interplay of α-synuclein with lipids in the central nervous system and its implications for the pathogenesis of Parkinson's disease[J]. Int J Mol Sci，2023，24（17）：13270. DOI：10.3390/ijms241713270.
[31]	PAN Y，ZONG Q L，LI G X，et al. Nuclear localization of alpha-synuclein induces anxiety-like behavior in mice by decreasing hippocampal neurogenesis and pathologically affecting amygdala circuits[J]. Neurosci Lett，2023，816：137490. DOI：10.1016/j.neulet.2023.137490.
[32]	张林凤. 哈氏疏肝健脾汤治疗围绝经期抑郁的疗效研究及对α-突触核蛋白、突触素1的影响[D]. 天津：天津中医药大学，2023.
[33]	INGÓLFSSON H I，CARPENTER T S，BHATIA H，et al. Computational lipidomics of the neuronal plasma membrane[J]. Biophys J，2017，113（10）：2271-2280. DOI：10.1016/j.bpj.2017.10.017.
[34]	BERTHOU C，ILIOU J P，BARBA D. Iron，neuro-bioavailability and depression[J]. EJHaem，2021，3（1）：263-275. DOI：10.1002/jha2.321.
[35]	REICHERT C O，DE FREITAS F A，SAMPAIO-SILVA J，et al. Ferroptosis mechanisms involved in neurodegenerative diseases[J]. Int J Mol Sci，2020，21（22）：8765. DOI：10.3390/ijms21228765.
[36]	CAPELLETTI M M，MANCEAU H，PUY H，et al. Ferroptosis in liver diseases：an overview[J]. Int J Mol Sci，2020，21（14）：4908. DOI：10.3390/ijms21144908.
[37]	ANGELOVA P R，CHOI M L，BEREZHNOV A V，et al. Alpha synuclein aggregation drives ferroptosis：an interplay of iron，calcium and lipid peroxidation[J]. Cell Death Differ，2020，27（10）：2781-2796. DOI：10.1038/s41418-020-0542-z.
[38]	WANG Y，WANG S W，XIN Y，et al. Hydrogen sulfide alleviates the anxiety-like and depressive-like behaviors of type 1 diabetic mice via inhibiting inflammation and ferroptosis[J]. Life Sci，2021，278：119551. DOI：10.1016/j.lfs.2021.119551.
[39]	ZHANG W X，YU M Q，ZHANG Q Y，et al. DFO treatment protects against depression-like behaviors and cognitive impairment in CUMS mice[J]. Brain Res Bull，2022，187：75-84. DOI：10.1016/j.brainresbull.2022.06.016.
[40]	DANG R Z，WANG M Y，LI X H，et al. Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1/Nrf2/HO-1/Gpx4 pathway[J]. J Neuroinflammation，2022，19（1）：41. DOI：10.1186/s12974-022-02400-6.
[41]	ZOU L L，TIAN Y L，WANG Y F，et al. High-cholesterol diet promotes depression- and anxiety-like behaviors in mice by impact gut microbe and neuroinflammation[J]. J Affect Disord，2023，327：425-438. DOI：10.1016/j.jad.2023.01.122.
[42]	AGUS A，CLÉMENT K，SOKOL H. Gut microbiota-derived metabolites as central regulators in metabolic disorders[J]. Gut，2021，70（6）：1174-1182. DOI：10.1136/gutjnl-2020-323071.
[43]	HIGARZA S G，ARBOLEYA S，ARIAS J L，et al. Akkermansia muciniphila and environmental enrichment reverse cognitive impairment associated with high-fat high-cholesterol consumption in rats[J]. Gut Microbes，2021，13（1）：1-20. DOI：10.1080/19490976.2021.1880240.
[44]	GUO H J，LIU X X，CHEN T，et al. Akkermansia muciniphila improves depressive-like symptoms by modulating the level of 5-HT neurotransmitters in the gut and brain of mice[J]. Mol Neurobiol，2024，61（2）：821-834. DOI：10.1007/s12035-023-03602-6.
[45]	JIANG W X，CHEN J J，GONG L，et al. Microbiota-derived short-chain fatty acids may participate in post-stroke depression by regulating host's lipid metabolism[J]. J Psychiatr Res，2023，161：426-434. DOI：10.1016/j.jpsychires.2023.03.032.
[46]	CHEN Y，LI J R，LE D S，et al. A mediation analysis of the role of total free fatty acids on pertinence of gut microbiota composition and cognitive function in late life depression[J]. Lipids Health Dis，2024，23（1）：64. DOI：10.1186/s12944-024-02056-6.
[47]	DE VOS W M，TILG H，VAN HUL M，et al. Gut microbiome and health：mechanistic insights[J]. Gut，2022，71（5）：1020-1032. DOI：10.1136/gutjnl-2021-326789.
[48]	SURMA M，ANBARASU K，DUTTA S，et al. Enhanced mitochondrial biogenesis promotes neuroprotection in human pluripotent stem cell derived retinal ganglion cells[J]. Commun Biol，2023，6（1）：218. DOI：10.1038/s42003-023-04576-w.
[49]	YANG C X，SUI G H，LI D，et al. Exogenous IGF-1 alleviates depression-like behavior and hippocampal mitochondrial dysfunction in high-fat diet mice[J]. Physiol Behav，2021，229：113236. DOI：10.1016/j.physbeh.2020.113236.
[50]	LOU G F，PALIKARAS K，LAUTRUP S，et al. Mitophagy and neuroprotection[J]. Trends Mol Med，2020，26（1）：8-20. DOI：10.1016/j.molmed.2019.07.002.
[51]	SONG Y，CAO H，ZUO C C，et al. Mitochondrial dysfunction：a fatal blow in depression[J]. Biomedecine Pharmacother，2023，167：115652. DOI：10.1016/j.biopha.2023.115652.
[52]	LI W F，ALI T，HE K W，et al. ApoE4 dysregulation incites depressive symptoms and mitochondrial impairments in mice[J]. J Cell Mol Med，2024，28（7）：e18160. DOI：10.1111/jcmm.18160.
[53]	CHEN X P，LIU Y Y，PU J C，et al. Proteomics reveals mitochondrial dysfunction and energy metabolism disturbance of intestine in a nonhuman primate model of depression[J]. J Affect Disord，2023，333：562-570. DOI：10.1016/j.jad.2023.04.031.
[54]	SHEN J D，ZHANG Y W，WANG B Y，et al. Effects of resveratrol on the levels of ATP，5-HT and GAP-43 in the hippocampus of mice exposed to chronic unpredictable mild stress[J]. Neurosci Lett，2020，735：135232. DOI：10.1016/j.neulet.2020.135232.
[55]	程文静，李鹏，陈文婕，等. 针刺对抑郁大鼠海马PINK1-Parkin信号通路介导线粒体自噬表达的影响[J]. 中华中医药杂志，2023，38（1）：361-366.
[56]	KIM E Y，CHOI J E，KIM M，et al. N-3 PUFA have antidepressant-like effects via improvement of the HPA-axis and neurotransmission in rats exposed to combined stress[J]. Mol Neurobiol，2020，57（9）：3860-3874. DOI：10.1007/s12035-020-01980-9.
[57]	WANG B，WU L J，CHEN J，et al. Metabolism pathways of arachidonic acids：mechanisms and potential therapeutic targets[J]. Signal Transduct Target Ther，2021，6（1）：94. DOI：10.1038/s41392-020-00443-w.
[58]	DEMERS G，ROY J，MACHUCA-PARRA A I，et al. Fish oil supplementation alleviates metabolic and anxiodepressive effects of diet-induced obesity and associated changes in brain lipid composition in mice[J]. Int J Obes，2020，44（9）：1936-1945. DOI：10.1038/s41366-020-0623-6.
[59]	杨吉娜. 甘草苷抗抑郁作用拟靶向代谢组学和脂质组学研究[D]. 广州：华南理工大学，2020.
[60]	周巧. 基于甘油磷脂代谢探讨黄葵总黄酮治疗伴抑郁状态溃疡性结肠炎机制研究[D]. 南京：南京中医药大学，2023.

脂质代谢异常与抑郁症发展的关联及机制研究进展

Exploration of the Association and Mechanism between Abnormal Lipid Metabolism and Depressive Development

RichHTML

PDF

PDF (英文版)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 60

相关文章 15

编辑推荐

Metrics

留言

[1]	王婷婷, 唐勇, 张文轲, 李志刚. 高尿酸血症运动干预的研究进展[J]. 中国全科医学, 2025, 28(30): 3841-3846.
[2]	赵紫淇, 陈嘉琦, 朱红敏, 郑一展, 王欢, 胡佳琪, 刘明月, 王楠, 罗政豪, 陈新洋, 李峥, 张尚明珠, 张皓若, 宣小庆, 武建辉, 张秀军. 社区人群社会支持与抑郁症关系的横断面研究[J]. 中国全科医学, 2025, 28(29): 3660-3667.
[3]	周晟, 邓长生, 邹冠炀, 宋健平. 疟疾心血管疾病并发症发病机制的研究进展[J]. 中国全科医学, 2025, 28(27): 3466-3472.
[4]	杨涵单, 乔雯, 何姝, 陈易, 童云梅. 接纳承诺疗法联合舍曲林对抑郁症青少年抑郁情绪、自杀意念及睡眠质量的影响研究[J]. 中国全科医学, 2025, 28(22): 2813-2818.
[5]	刘宇婷, 仇丽霞, 李育玲. 衰弱对中国老年人认知功能的影响：有调节的链式中介效应研究[J]. 中国全科医学, 2025, 28(17): 2119-2126.
[6]	陈钡钡, 李佳, 谭文彬. 内分泌代谢系统疾病与继发性骨质疏松症的研究新进展[J]. 中国全科医学, 2025, 28(17): 2082-2091.
[7]	章琪, 和申, 李华. 2022年美国预防临床服务指南工作组《儿童和青少年抑郁症和自杀风险筛查推荐声明》解读[J]. 中国全科医学, 2025, 28(15): 1823-1830.
[8]	王宇新, 彭文婉, 周正, 黄海阳, 卢晓敏, 董明国. 胃癌前状态的癌变风险及其发病机制的研究进展[J]. 中国全科医学, 2025, 28(11): 1411-1416.
[9]	裴金英, 宋金洲, 马到丰, 罗孝廷, 刘斌, 董晓红, 丛树园. 中药提取物调控铁死亡改善阿尔茨海默病的研究新进展[J]. 中国全科医学, 2025, 28(05): 639-648.
[10]	罗宇, 罗丹, 唐彬秩. 肠道菌群：儿童肥胖的重要参与者[J]. 中国全科医学, 2024, 27(33): 4182-4189.
[11]	郁海东, 潘苗苗, 顾红琴, 刘涛, 戴洁, 刘玲华, 侯俊平, 杨丽, 施美芳, 赵超. 社区老年人抑郁和认知状况与营养代谢的关联性研究[J]. 中国全科医学, 2024, 27(28): 3540-3545.
[12]	张珊, 张萌, 徐欣, 廖丽鑫, 孙明军, 马海燕, 张海滨, 郭钰珍. 卵巢畸胎瘤相关抗N-甲基-D-天冬氨酸受体脑炎发病机制及诊疗研究进展[J]. 中国全科医学, 2024, 27(24): 3038-3043.
[13]	陈领, 孔晓明, 孙艳, 洪虹, 张丽. 合并亚临床甲状腺功能减退老年抑郁症住院患者的临床特征分析[J]. 中国全科医学, 2024, 27(24): 2982-2986.
[14]	梁万年. 构建优质高效的整合型卫生健康体系[J]. 中国全科医学, 2024, 27(19): 2301-2304.
[15]	庞兰, 李佩璠, 朱晓岗, 杨再红, 郑蕾. 深部经颅磁刺激联合草酸艾司西酞普兰治疗抑郁症的疗效：一项随机对照试验[J]. 中国全科医学, 2024, 27(17): 2098-2103.